newsfilter
← Latest News
GlobeNewswire·

ARCA biopharma Announces First Quarter 2021 Financial Results and Provides Corporate Update

Topline data from Phase 2b clinical trial evaluating rNAPc2 as a potential treatment for COVID-19 anticipated in the third quarter of 2021 WESTMINSTER, Colo., May 11, 2021 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (NASDAQ:ABIO), a biopharmaceutical